Pharma-Bio Serv (PBSV) Liabilities and Shareholders Equity (2016 - 2025)
Historic Liabilities and Shareholders Equity for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to $13.7 million.
- Pharma-Bio Serv's Liabilities and Shareholders Equity fell 1619.9% to $13.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $57.2 million, marking a year-over-year decrease of 1679.15%. This contributed to the annual value of $13.7 million for FY2025, which is 1619.9% down from last year.
- Per Pharma-Bio Serv's latest filing, its Liabilities and Shareholders Equity stood at $13.7 million for Q4 2025, which was down 1619.9% from $13.6 million recorded in Q3 2025.
- Pharma-Bio Serv's 5-year Liabilities and Shareholders Equity high stood at $30.2 million for Q1 2021, and its period low was $13.6 million during Q3 2025.
- For the 5-year period, Pharma-Bio Serv's Liabilities and Shareholders Equity averaged around $20.1 million, with its median value being $20.0 million (2022).
- As far as peak fluctuations go, Pharma-Bio Serv's Liabilities and Shareholders Equity soared by 1543.86% in 2021, and later crashed by 2890.68% in 2022.
- Over the past 5 years, Pharma-Bio Serv's Liabilities and Shareholders Equity (Quarter) stood at $23.9 million in 2021, then dropped by 13.67% to $20.7 million in 2022, then fell by 3.63% to $19.9 million in 2023, then decreased by 18.14% to $16.3 million in 2024, then fell by 16.2% to $13.7 million in 2025.
- Its last three reported values are $13.7 million in Q4 2025, $13.6 million for Q3 2025, and $13.9 million during Q2 2025.